Table 3

 Modalities of treatment of all lung cancers diagnosed in the year 2000 in Teesside and Varese

Teesside†Varese‡p value
Data are presented as number of patients with percentage of total valid cases.
*All 17 cases were NSCLC clinical stage I–II.
†Total valid cases in Teesside  =  261/268; the other seven patients moved to other districts and their treatment could not be traced.
‡Total valid cases in Varese  =  243.
§Resection rate of NSCLC clinical stage I–II was 17/37 (46%) in Teesside and 44/53 (83%) in Varese (p<0.001).
¶Including 44 NSCLC stage I–II, 8 NSCLC stage III A, 5 NSCLC stage IIIB–IV (satellite nodule), and 2 SCLC (limited disease).
Surgical resection§17 (7%)*59 (24%)¶<0.001
Radical radiotherapy (⩾50 Gy)1 (0.4%)2 (0.8%)0.522
Palliative radiotherapy66 (25%)54 (22%)0.420
Chemotherapy35 (13%)45 (19%)0.117
Radiotherapy + chemotherapy12 (5%)23 (9%)0.032
No active cancer treatment130 (50%)60 (25%)<0.001